Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Treatment for Elderly Symptomatic CAD
NCT07041359Phase 4Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Compound Danshen and qishen yiqi dripping pills in coronary artery disease (CAD) and angina pectoris (4 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoints: Seattle Angina Questionnaire at 12 weeks, Canadian Cardiovascular Society grading of angina pectoris at 12 weeks and 2 more. Started Aug 2025; status: recruiting.
02
Drugs
Compound Danshenqishen yiqi dripping pills
03
Conditions
coronary artery disease (CAD)angina pectoris
Beyond the preview
Go deeper on NCT07041359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07041359.